ARCHIVES

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

This article is from The Cancer Letter archive.

Vol. 15 No. 36 | September 22, 1989

Download PDF Visit The Full Archive

Related Articles

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Experts Concerned As Phase I Studies Reach Deeper Into Community Practice (Second story in a two-part series.)

April 2, 2010

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

October 8, 2010

Contract Awards Sole Source Negotiations

January 13, 1978

In Brief: Discoverer Of H. Pylori Role In Ulcers Wins Lasker Foundation Clinical Research Award

October 6, 1995

Skipper To Receive Bristol-Myers Award

March 14, 1980